ARTICLE | Finance
Aiming for rare disease niche, Europe biotech vets form Sound Bioventures
With €110M first close completed, Swedish VC led by Breum, Kördel, Mukhopadhyay will seek to back programs entering or nearing the clinic
January 4, 2022 11:57 PM UTC
Newly launched Sound Bioventures believes it can draw on its partners’ expertise to invest in niche areas, amid an environment in which European VCs are raising their biggest funds ever.
Sound said Tuesday it had raised €110 million ($124.8 million) toward its first fund. Founding partner Bibhash Mukhopadhyay told BioCentury the firm is aiming for a €150 million final close, but could exceed that figure, with a hard cap of €200 million...